In this segment, Dr. Rodriguez sketches how she began to shift away from research as her main focus. She began, she says, by doing administrative work “in a surreptitious way.” Dr. Cabanillas asked her to serve as Director of the Lymphoma Clinic, a role that gave her experience, demonstrated her knack for administration, and her commitment to making things better for patients. She talks about working with clinical pharmacists, a new breed of specialists at MD Anderson, and the roles this connection led to. Dr. Rodriguez then talks about how important grantsmanship is for researchers.https://openworks.mdanderson.org/mchv_interviewchapters/1335/thumbnail.jp
In this chapter, Dr. Mills begins sketching his approach to rebuilding the Department of Systems Bio...
Dr. Rodriguez begins this segment by explaining how her view of the institution changed as she stepp...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...
In this segment, Dr. Rodriguez sketches how she began to shift away from research as her main focus....
To begin this segment, Dr. Rodriguez sketches her research while a Fellow at the University of Arizo...
In this chapter, Dr. Buzdar talks about his role as Vice President of Clinical Research, an office t...
Dr. Elting begins this chapter by explaining that the threat of infections was decreasing and so she...
Dr. Cohen first tells the story of applying for a position at MD Anderson, noting that he wanted to ...
In this segment, Dr. Rodriguez describes studies she conducted on lymphoma treatments in collaborati...
Dr. Rodriguez states that MD Anderson has shifted away from its mission as a care facility since Ron...
In this segment, Dr. Rodriguez talks about her residency and her decision to focus on oncology. She...
Dr. Kripke begins this segment by further detailing her role as Vice President and Executive Vice Pr...
Dr. Becker talks about efforts to expand MD Anderson and try innovative administrative approaches. ...
In this chapter, Dr. Dmitrovsky outlines the factors that led to him leaving Dartmouth and taking a ...
In this segment, Dr. Kripke covers her arrival at MD Anderson (Hospital and Tumor Institute) in 1983...
In this chapter, Dr. Mills begins sketching his approach to rebuilding the Department of Systems Bio...
Dr. Rodriguez begins this segment by explaining how her view of the institution changed as she stepp...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...
In this segment, Dr. Rodriguez sketches how she began to shift away from research as her main focus....
To begin this segment, Dr. Rodriguez sketches her research while a Fellow at the University of Arizo...
In this chapter, Dr. Buzdar talks about his role as Vice President of Clinical Research, an office t...
Dr. Elting begins this chapter by explaining that the threat of infections was decreasing and so she...
Dr. Cohen first tells the story of applying for a position at MD Anderson, noting that he wanted to ...
In this segment, Dr. Rodriguez describes studies she conducted on lymphoma treatments in collaborati...
Dr. Rodriguez states that MD Anderson has shifted away from its mission as a care facility since Ron...
In this segment, Dr. Rodriguez talks about her residency and her decision to focus on oncology. She...
Dr. Kripke begins this segment by further detailing her role as Vice President and Executive Vice Pr...
Dr. Becker talks about efforts to expand MD Anderson and try innovative administrative approaches. ...
In this chapter, Dr. Dmitrovsky outlines the factors that led to him leaving Dartmouth and taking a ...
In this segment, Dr. Kripke covers her arrival at MD Anderson (Hospital and Tumor Institute) in 1983...
In this chapter, Dr. Mills begins sketching his approach to rebuilding the Department of Systems Bio...
Dr. Rodriguez begins this segment by explaining how her view of the institution changed as she stepp...
Dr. Bast begins this chapter by reviewing his reasons for leaving his role as head of the cancer cen...